Clinical Observation of Dexmedetomidine Sedation in Patients Undergoing Percutaneous Nephrolithotomy with Spinal Anesthesia

Cui Shihe,Ma Zhengliang

DOI: https://doi.org/10.3969/j.issn.1673-548X.2012.12.048

2012-01-01

Abstract:Objective To investigate the clinical efficacy and effective dose of dexmedetomidine sedation in patients undergoing percutaneous nephrolithotomy with spinal anesthesia.Methods Fourty ASA Ⅰ-Ⅱ patients scheduled for percutaneous nephrolithotomy under spinal anesthesia were randomly allocated to four groups(D0,D1,D2,D4),with 10 patients in each group.Before operation,Patients in group D1,D2,D4,received DEX 1.0μg/kg within 10min,then 0.1μg/(kg·h),0.2μg/(kg·h),0.4μg/(kg·h),infusion until the end of surgery,respectively,while group D0 were administered normal saline 10ml/h.HR,MAP,SpO2,OAA / S at the recorded time points,as well as adverse events such as respiratory depression,severe brady cardia,perioperative shivering were assessed.Results When T1 compared with T2 in each group,HR and OAA/S scores were significantly decreased(P<0.05).When Ta compared with Tb in each group,OAA/S scores were significantly increased in group D2,D4(P<0.05).Compared to group D0,group D2 and D4 had significantly difference in HR and OAA / S scores between T3and T6.Compared to group D2,group D4 had significantly difference in SpO2 and OAA / S scores at the same time.Conclusion Perioperative dexmedetomidine infusion can provide sedative,antianxiety effect in patients undergoing percutaneous nephrolithotomy,with stable hemodynamics and decreased incidence of shivering.The most reasonable dose regimen is loading dose 1.0μg/kg,followed by an infusion rate 0.2μg/(kg·h).